Abstract
Concerns regarding publicly traded companies' R&D investment have long existed among academics domestically and overseas. Scholars have conducted much research on the R&D investment of enterprises from different angles. This study starts from the perspective of market expectation and loss aversion, taking the data of Chinese quoted companies from 2011 to 2020 as a sample and using the empirical analysis method to research the impact of changes in market value on quoted companies' innovation decisions. Robustness tests effectively corroborate the findings of the study, which found a substantial positive association between changes in the market value of listed businesses and the degree of innovation investment. Additionally, this study conducts a group regression test on the R&D investment growth rate (RDI) of state-owned companies (SOEs) and non-state-owned firms using the two explanatory variables of total market value growth rate (RDI) and Tobin's Q value (Tobin's Q) (NSOEs). It is discovered that NSOEs are more vulnerable to market capitalization change than SOEs are, and the listed businesses' intentions to innovate are influenced by changes in market capitalization through the loss aversion mechanism.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
